The Insider Jeffrey Williams Unloaded 15653 shares of Apple Inc. (AAPL); Egalet (EGLT) Has 0.7 Sentiment

June 13, 2018 - By Danny Collins

Egalet Corporation (NASDAQ:EGLT) Logo

Egalet Corp (EGLT) investors sentiment increased to 0.7 in 2018 Q1. It’s up 0.23, from 0.47 in 2017Q4. The ratio is better, as 14 active investment managers increased and opened new holdings, while 20 reduced and sold their equity positions in Egalet Corp. The active investment managers in our database now possess: 12.28 million shares, down from 13.62 million shares in 2017Q4. Also, the number of active investment managers holding Egalet Corp in top ten holdings was flat from 0 to 0 for the same number . Sold All: 8 Reduced: 12 Increased: 10 New Position: 4.

Highbridge Capital Management Llc holds 0.03% of its portfolio in Egalet Corporation for 3.23 million shares. Nj State Employees Deferred Compensation Plan owns 200,000 shares or 0.02% of their US portfolio. Moreover, Advisory Services Network Llc has 0% invested in the company for 1,835 shares. The Illinois-based Alyeska Investment Group L.P. has invested 0% in the stock. Atlantic Trust Group Llc, a Georgia-based fund reported 15,000 shares.

The stock increased 10.35% or $0.0474 during the last trading session, reaching $0.5055. About 1.44M shares traded or 103.09% up from the average. Egalet Corporation (EGLT) has declined 81.41% since June 13, 2017 and is downtrending. It has underperformed by 93.98% the S&P500. Some Historical EGLT News: ; 29/05/2018 – Egalet Announces Large Regional Plan to Cover SPRIX® Nasal Spray; 30/04/2018 – Egalet Presented Data at American Academy of Pain Medicine Examining the Potential of ARYMO® ER to Deter Opioid Abuse; 12/03/2018 – Egalet 4Q Rev $7.8M; 29/05/2018 – EGALET REPORTS LARGE REGIONAL PLAN TO COVER SPRIX® NASAL SPRAY; 07/05/2018 – EGALET – A NATIONAL PHARMACY BENEFIT MANAGER HAS PLACED ARYMO ER EXTENDED-RELEASE TABLETS FOR ORAL USE ONLY -Cll IN TIER 3 UNRESTRICTED POSITION; 05/04/2018 – EGALET – LAWSUIT FILED FOR TEVA’S INFRINGEMENT OF A PATENT FOR ARYMO ER LISTED IN APPROVED DRUG PRODUCTS WITH THERAPEUTIC EQUIVALENCE EVALUATIONS; 17/04/2018 – Egalet Announces Two Large Northeast Regional Health Plans Placed ARYMO® ER in Preferred Formulary Position; 29/05/2018 – EGALET SAYS LARGE SOUTHEAST REGIONAL HEALTH PLAN TO COVER SPRIX; 05/04/2018 – EGALET SAYS FILED PATENT INFRINGEMENT SUIT AGAINST TEVA USA; 08/05/2018 – EGALET CORP – NET PRODUCT SALES OF $6.3 MLN FOR QUARTER ENDED MARCH 31, 2018 COMPARED TO $5.4 MLN

Egalet Corporation, a specialty pharmaceutical company, develops, makes, and commercializes treatments for patients with pain and other conditions. The company has market cap of $26.72 million. It has licensed three approved pain products, such as SPRIX Nasal Spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; OXAYDO, an immediate-release oxycodone product designed to discourage abuse via snorting for the management of acute and chronic moderate to severe pain where an opioid is appropriate; and ARYMO ER, an extended-release morphine product formulated with abuse-deterrent (AD) properties for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. It currently has negative earnings. The firm is also developing Egalet-002, a Guardian Technology AD, ER, oral oxycodone formulation, which is in Phase III clinical trials for the same indication as ARYMO ER.

Analysts await Egalet Corporation (NASDAQ:EGLT) to report earnings on August, 8. They expect $-0.21 earnings per share, up 79.81% or $0.83 from last year’s $-1.04 per share. After $-0.26 actual earnings per share reported by Egalet Corporation for the previous quarter, Wall Street now forecasts -19.23% EPS growth.

Another recent and important Egalet Corporation (NASDAQ:EGLT) news was published by Seekingalpha.com which published an article titled: “FDA OKs first non-opioid treatment for opioid withdrawal” on May 16, 2018.

Apple Inc. designs, manufactures, and markets mobile communication and media devices, and personal computers to consumers, and small and mid-sized businesses; and education, enterprise, and government clients worldwide. The company has market cap of $945.08 billion. The firm also sells related software, services, accessories, networking solutions, and third-party digital content and applications. It has a 18.6 P/E ratio. It offers iPhone, a line of smartphones; iPad, a line of multi-purpose tablets; and Mac, a line of desktop and portable personal computers, as well as operating systems comprising iOS, macOS, watchOS, and tvOS.

Since January 5, 2018, it had 0 insider purchases, and 11 selling transactions for $48.11 million activity. $6.51M worth of Apple Inc. (NASDAQ:AAPL) was sold by LEVINSON ARTHUR D on Wednesday, May 9. 17,372 shares were sold by Riccio Daniel J., worth $3.26 million on Thursday, May 17. SCHILLER PHILIP W sold 69,491 shares worth $11.56 million. Srouji Johny sold 14,976 shares worth $2.81 million. $910,129 worth of Apple Inc. (NASDAQ:AAPL) shares were sold by KONDO CHRIS. WILLIAMS JEFFREY E sold 15,653 shares worth $2.90M. The insider Maestri Luca sold 4,769 shares worth $903,928.

Analysts await Apple Inc. (NASDAQ:AAPL) to report earnings on August, 7. They expect $2.19 EPS, up 31.14% or $0.52 from last year’s $1.67 per share. AAPL’s profit will be $10.76B for 21.95 P/E if the $2.19 EPS becomes a reality. After $2.73 actual EPS reported by Apple Inc. for the previous quarter, Wall Street now forecasts -19.78% negative EPS growth.

The COO of Apple Inc, Jeffrey Williams, has just unloaded – 15,653 shares of the corporation he’s supervising and operating – coming to a cumulative trade value of $2,988,851 USD (this based on avg share price of $190.9). This trade was pretty significant, so clearly it won’t go unseen. Presently, he has rights to a total of 139,389 shares or 0.00% of the Company’s market capitalization (total value of the shares outstanding).

The stock increased 0.55% or $1.05 during the last trading session, reaching $192.28. About 14.85 million shares traded. Apple Inc. (NASDAQ:AAPL) has risen 22.56% since June 13, 2017 and is uptrending. It has outperformed by 9.99% the S&P500. Some Historical AAPL News: ; 23/05/2018 – MacDailyNews: Apple takes different tack than Amazon, secretly searches for new east coast campus; 20/04/2018 – Apple Says It Will Replace Some MacBook Pro Laptop Batteries; 11/03/2018 – The Chinese yuan is growing in purchasing power, making Apple, Boeing and Delta more enticing to Chinese buyers. But if U.S. regulators raise more red flags about such transactions, it could start to stir some serious threats to capitalism; 04/04/2018 – Bloomberg Asia: EXCLUSIVE: Apple is working on touchless control and a curved iPhone screen; 15/05/2018 – Moody’s Assigns Casablanca’s (Apple Leisure Group) Proposed Bank Facility A B3; B3 Cfr Affirmed; 28/03/2018 – Apple seeks to take advantage of Facebook’s woes; 25/04/2018 – Trump and Apple CEO Cook meet at White House with trade the focus; 04/04/2018 – Apple Working on Touchless Control, Curved Screen for IPhones (Video); 30/05/2018 – Matterport Appoints Media Technology Leader Chris Bell as CMO; 25/05/2018 – Apple to Close Atlantic City Store, Cutting 52 Employees

More notable recent Apple Inc. (NASDAQ:AAPL) news were published by: Seekingalpha.com which released: “Apple: Too Big To Miss” on June 13, 2018, also Seekingalpha.com with their article: “Apple cracks down on apps collecting contact data” published on June 12, 2018, Seekingalpha.com published: “This Is Apple’s Rocket Fuel” on June 12, 2018. More interesting news about Apple Inc. (NASDAQ:AAPL) were released by: Nasdaq.com and their article: “Tuesday Apple Rumors: Apple is Still Working on Waterproof iPhone” published on June 12, 2018 as well as Livetradingnews.com‘s news article titled: “Apple Inc. (NASDAQ:AAPL) Making a New High This Week” with publication date: June 12, 2018.

Investors sentiment decreased to 0.69 in Q1 2018. Its down 0.04, from 0.73 in 2017Q4. It dived, as 69 investors sold Apple Inc. shares while 1039 reduced holdings. 125 funds opened positions while 645 raised stakes. 2.86 billion shares or 3.74% less from 2.98 billion shares in 2017Q4 were reported. Advantus Capital Mngmt Inc reported 2.24% in Apple Inc. (NASDAQ:AAPL). Ar Asset stated it has 76,615 shares or 5.17% of all its holdings. Alps reported 54,994 shares stake. Riggs Asset Managment Inc has invested 2.45% of its portfolio in Apple Inc. (NASDAQ:AAPL). Johnson Finance Group Incorporated invested in 83,353 shares or 1.67% of the stock. The Massachusetts-based New England Inv & Retirement Group Inc has invested 1.83% in Apple Inc. (NASDAQ:AAPL). Texas Yale Cap has invested 0.74% in Apple Inc. (NASDAQ:AAPL). Moreover, Virginia Retirement System Et Al has 3.04% invested in Apple Inc. (NASDAQ:AAPL). Moreover, Welch Group Lc has 0.49% invested in Apple Inc. (NASDAQ:AAPL) for 23,194 shares. Cap City Trust Fl accumulated 34,010 shares. Fred Alger Mngmt Incorporated accumulated 4.41M shares or 3.44% of the stock. Primecap Company Ca stated it has 0.11% in Apple Inc. (NASDAQ:AAPL). Trillium Asset Mgmt Lc invested in 129,850 shares. Magellan Asset Mgmt stated it has 10.68M shares or 6.61% of all its holdings. Van Cleef Asset Managementinc reported 169,941 shares or 7.03% of all its holdings.

Egalet Corporation (NASDAQ:EGLT) Institutional Positions Chart